740
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Underutilization of Pulmonary Function Testing in Veterans Hospitalized for Chronic Obstructive Pulmonary Disease Exacerbation: Who are We Missing?

, , , , , , , , & show all
Pages 15-21 | Received 24 Nov 2019, Accepted 23 Dec 2019, Published online: 17 Jan 2020

References

  • Centers for Disease Control and Prevention. Mortality in the United States, 2017. 2017; https://www.cdc.gov/nchs/products/databriefs/db328.htm.
  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP.
  • American Lung Association. How Serious is COPD. 2018. https://www.lung.org/lung-health-and-diseases/lung-disease-lookup/copd/learn-about-copd/how-serious-is-copd.html.
  • Ford ES, Croft JB, Mannino DM, et al. COPD surveillance–United States, 1999-2011. Chest. 2013;144(1):284–305. doi:10.1378/chest.13-0809.
  • Lee TA, Bartle B, Weiss KB. Spirometry use in clinical practice following diagnosis of COPD. Chest. 2006;129(6):1509–1515. doi:10.1378/chest.129.6.1509.
  • Arne M, Lisspers K, Stallberg B, et al. How often is diagnosis of COPD confirmed with spirometry?. Respir Med. 2010;104(4):550–556. doi:10.1016/j.rmed.2009.10.023.
  • Han MK, Kim MG, Mardon R, et al. Spirometry utilization for COPD: how do we measure up?. Chest. 2007;132(2):403–409. doi:10.1378/chest.06-2846.
  • Gershon AS, Hwee J, Croxford R, et al. Patient and physician factors associated with pulmonary function testing for COPD: a population study. Chest. 2014;145(2):272–281. doi:10.1378/chest.13-0790.
  • Gershon A, Mecredy G, Croxford R, et al. Outcomes of patients with chronic obstructive pulmonary disease diagnosed with or without pulmonary function testing. CMAJ. 2017;189(14):E530–E538. doi:10.1503/cmaj.151420.
  • Veterans Health Administration. About VHA. 2018. https://www.va.gov/health/aboutvha.asp.
  • Goulet JL, Kerns RD, Bair M, et al. The musculoskeletal diagnosis cohort: examining pain and pain care among veterans. Pain. 2016;157(8):1696–1703. doi:10.1097/j.pain.0000000000000567.
  • Higgins DM, Fenton BT, Driscoll MA, et al. Gender differences in demographic and Clinical correlates among Veterans with musculoskeletal disorders. Womens Health Issues. 2017;27(4):463–470. doi:10.1016/j.whi.2017.01.008.
  • Thompson WH, St-Hilaire S. Prevalence of chronic obstructive pulmonary disease and tobacco use in veterans at Boise Veterans Affairs Medical Center. Respir Care. 2010;55(5):555–560.
  • Bade BC, DeRycke EC, Ramsey C, et al. Sex differences in Veterans admitted to the hospital for COPD exacerbation. Ann Am Thorac Soc. 2019;16(6):707–714.
  • MacIntyre NR, Foss CM. Pulmonary function testing: coding and billing issues. Respir Care. 2003;48(8):786–790.
  • McGinnis KA, Brandt CA, Skanderson M, et al. Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source. Nicotine Tob Res. 2011;13(12):1233–1239. doi:10.1093/ntr/ntr206.
  • Rinne ST, Elwy AR, Liu CF, et al. Implementation of guideline-based therapy for chronic obstructive pulmonary disease: Differences between men and women veterans. Chron Respir Dis. 2017;14(4):385–391. doi:10.1177/1479972317702141.
  • Aryal S, Diaz-Guzman E, Mannino DM. COPD and gender differences: an update. Transl Res. 2013;162(4):208–218. doi:10.1016/j.trsl.2013.04.003.
  • Camp PG, Goring SM. Gender and the diagnosis, management, and surveillance of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007;4(8):686–691. doi:10.1513/pats.200706-081SD.
  • Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest. 2001;119(6):1691–1695. doi:10.1378/chest.119.6.1691.
  • Varkey AB. Chronic obstructive pulmonary disease in women: exploring gender differences. Curr Opin Pulm Med. 2004;10(2):98–103. doi:10.1097/00063198-200403000-00003.
  • Sorheim IC, Johannessen A, Gulsvik A, et al. Gender differences in COPD: are women more susceptible to smoking effects than men?. Thorax. 2010;65(6):480–485. doi:10.1136/thx.2009.122002.
  • Prescott E, Bjerg AM, Andersen PK, et al. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J. 1997;10(4):822–827.
  • Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs RW, et al. Trends and patterns of differences in chronic respiratory disease mortality among US counties, 1980-2014. JAMA 2017;318(12):1136–1149. doi:10.1001/jama.2017.11747.
  • Herrick H, Pleasants R, Wheaton AG, et al. Chronic obstructive pulmonary disease and associated health-care resource use-North Carolina, 2007 and 2009 (Reprinted from MMWR, vol 61, pg 143-146, 2012. JAMA J Am Med Assoc. 2012;307(18):1905–1908.
  • Mowls DS, Cheruvu VK, Schilz R, et al. COPD in a nationally representative sample: sociodemographic factors and co-morbidity, diagnosis method, and healthcare utilization. COPD. 2015;12(1):96–103. doi:10.3109/15412555.2014.922065.
  • Mamary AJ, Stewart JI, Kinney GL, et al. Race and gender disparities are evident in COPD underdiagnoses across all severities of measured airflow obstruction. Chronic Obstr Pulm Dis. 2018;5(3):177–184. doi:10.15326/jcopdf.5.3.2017.0145.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.21551.
  • Bach PB, Cramer LD, Warren JL, et al. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341(16):1198–1205. doi:10.1056/NEJM199910143411606.
  • Tanner NT, Gebregziabher M, Hughes Halbert C, et al. Racial differences in outcomes within the National Lung Screening trial. Implications for widespread implementation. Am J Respir Crit Care Med. 2015;192(2):200–208. doi:10.1164/rccm.201502-0259OC.
  • Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System. 2019. https://www.cdc.gov/brfss/index.html.
  • Gershon AS, Macdonald EM, Luo J, et al. Concomitant pulmonologist and primary care for chronic obstructive pulmonary disease: a population study. Fam Pract. 2017;34(6):708–716. doi:10.1093/fampra/cmx058.
  • Jacobs DM, Noyes K, Zhao J, et al. Early hospital readmissions following an acute exacerbation of COPD in the nationwide readmissions database. Ann Am Thorac Soc. 2018;15:837–845.
  • Hegewald MJ, Gallo HM, Wilson EL. Accuracy and quality of spirometry in primary care offices. Annals ATS. 2016;13(12):2119–2124. doi:10.1513/AnnalsATS.201605-418OC.
  • Bambra G, Jalota L, Kapoor C, et al. Office spirometry correlates with laboratory spirometry in patients with symptomatic asthma and COPD. Clin Respir J. 2017;11(6):805–811. doi:10.1111/crj.12419.
  • Ruppel GL, Carlin BW, Hart M, et al. Office spirometry in primary care for the diagnosis and management of COPD: National Lung Health Education Program Update. Respir Care. 2018;63(2):242–252. doi:10.4187/respcare.05710.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.